Dr Wafa Al-Jamal wins GSK Emerging Scientist Award
Dr Wafa Al-Jamal, Prostate Cancer Research Fellow in the School of Pharmacy at UEA, has been announced as the winner of 2015 GSK Emerging Scientist Award for her exceptional work in the field of Nanomedicine. Wafa’s research focuses on developing nanoscale materials to deliver a wide range of therapeutics to cancer cells. Her long-term research career is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic.
The GSK Emerging Scientist Award has a long history with previous winners invariably going on to make significant contributions in the field of pharmaceutical science. The award is presented to a pharmaceutical scientist with no more than 10 years’ experience at post-doctoral level who has a proven record of independent research and published work that shows outstanding promise.
Dr Al-Jamal delivered her GSK Emerging Scientist Award Lecture “Developing Novel Nanomedicines to Treat Cancer” on 8 September 2015 at the 6th Academy of Pharmaceutical Sciences International PharmSci 2015 conference in Nottingham. The award was presented to her by Gordon Muirhead, GSK Vice President. She said: “I am thrilled to receive this prestigious award which recognises the hard work of my research group in the nanomedicine field. We are looking forward to improve patient diagnosis and treatment by developing new nanoparticle-based therapeutics and diagnostics. This award highly recognises the importance of translating our good science into industrial practice.”